Role of Growth Factor Receptor–Bound Protein 7 in Hepatocellular Carcinoma
Shinji Itoh(Kyushu University), Yoshihiko Maehara(Kyushu University), Norifumi Harimoto(National Kyushu Medical Center), Shinji Tanaka(Tokyo Institute of Technology), Mitsuo Shimada(Tokushima University), Yo‐ichi Yamashita(Kumamoto University), Akinobu Taketomi(Hokkaido University), Takashi Maeda(Kyushu University), Shin-ichi Aishima(Kyushu University), Ken Shirabe(Gunma University)
Cited by 40
Related Papers
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Randomized clinical trial of adjuvant gemcitabine chemotherapy <i>versus</i> observation in resected bile duct cancer
|British journal of surgery|2018|401
Interleukin‐6/<scp>STAT</scp>3 signaling as a promising target to improve the efficacy of cancer immunotherapy
|Cancer Science|2017|295
Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines)
|Hepatology Research|2023|281
Comprehensive molecular and immunological characterization of hepatocellular carcinoma
|EBioMedicine|2018|277